These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 9540034

  • 1. How well do patients with type 1 diabetes measure their blood glucose in daily life.
    Heinemann L, Overmann H, Mühlhauser I.
    Diabetes Care; 1998 Mar; 21(3):461-2. PubMed ID: 9540034
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Use of acarbose for eliminating the interval between meal consumption and insulin injection in patients with Type 1 diabetes.
    Koch HH, Wudy A, Eberlein G, Quast C.
    Diabetes Nutr Metab; 1999 Jun; 12(3):195-201. PubMed ID: 10554902
    [Abstract] [Full Text] [Related]

  • 5. Study: tight glucose control in diabetes lowers risk of atherosclerosis.
    FDA Consum; 2003 Jun; 37(4):10. PubMed ID: 12971340
    [No Abstract] [Full Text] [Related]

  • 6. [New insulin with uniform action. Hazards of blood sugar variations minimized].
    MMW Fortschr Med; 2003 Oct 02; 145(40):55. PubMed ID: 14603609
    [No Abstract] [Full Text] [Related]

  • 7. The Scylla and Charybdis of blood glucose control in children with diabetes mellitus.
    Sperling MA.
    J Pediatr; 1997 Mar 02; 130(3):339-41. PubMed ID: 9063403
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Treatment of type 1 diabetes with insulin lispro during Ramadan.
    Kadiri A, Al-Nakhi A, El-Ghazali S, Jabbar A, Al Arouj M, Akram J, Wyatt J, Assem A, Ristic S.
    Diabetes Metab; 2001 Sep 02; 27(4 Pt 1):482-6. PubMed ID: 11547222
    [Abstract] [Full Text] [Related]

  • 14. Benefits of continuous subcutaneous insulin infusion in type 1 diabetes previously treated with multiple daily injections with once-daily glargine and pre-meal analogues.
    Torres I, Ortego J, Valencia I, García-Palacios MV, Aguilar-Diosdado M.
    Exp Clin Endocrinol Diabetes; 2009 Sep 02; 117(8):378-85. PubMed ID: 19629931
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Continuous glucose monitoring: physiologic and pathophysiologic significance.
    Ionescu-Tîrgovişte C, Guja C, Ioacără S, Dumitrescu D, Tomescu I.
    Rom J Intern Med; 2004 Sep 02; 42(2):381-93. PubMed ID: 15529628
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.
    Ashwell SG, Gebbie J, Home PD.
    Diabet Med; 2006 Aug 02; 23(8):879-86. PubMed ID: 16911626
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.
    Cernea S, Kidron M, Wohlgelernter J, Raz I.
    Clin Ther; 2005 Oct 02; 27(10):1562-70. PubMed ID: 16330292
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.